This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
proper | frequency |
---|---|
COVID-19 | 510 |
GenV | 194 |
Health | 124 |
SARS | 114 |
Clinical | 103 |
Phase | 91 |
Fig | 90 |
• | 89 |
Trials | 79 |
CoV-2 | 77 |
China | 77 |
COPD | 76 |
Table | 73 |
Research | 72 |
IT | 70 |
iPad | 67 |
Data | 64 |
RCT | 63 |
RCTs | 63 |
Trial | 60 |
CI | 59 |
meta | 55 |
US | 54 |
United | 52 |
Committee | 50 |
FDA | 49 |
Coronavirus | 47 |
March | 46 |
University | 46 |
National | 46 |
TCM | 45 |
States | 45 |
International | 45 |
sha | 44 |
II | 42 |
ClinicalTrials.gov | 42 |
World | 41 |
Medical | 41 |
remdesivir | 41 |
Korea | 38 |
Hydroxychloroquine | 38 |
hydroxychloroquine | 37 |
Group | 37 |
DOI | 37 |
MERS | 36 |
April | 36 |
Meta | 35 |
Organization | 35 |
European | 34 |
ICU | 32 |
Drug | 31 |
ARDS | 31 |
Wuhan | 30 |
NAIROS | 30 |
J | 30 |
GCP | 30 |
Treatment | 29 |
UK | 29 |
ritonavir | 28 |
Disease | 28 |
Covid-19 | 28 |
Agency | 28 |
mg | 28 |
Efficacy | 27 |
Protection | 26 |
C | 26 |
Hospital | 26 |
Safety | 26 |
Remdesivir | 26 |
Study | 26 |
azithromycin | 26 |
Use | 25 |
ICH | 25 |
Care | 25 |
Administration | 25 |
Ebola | 24 |
AEs | 24 |
Food | 24 |
Medicines | 24 |
Society | 24 |
Norway | 23 |
June | 23 |
Cochrane | 23 |
COVID | 23 |
Analysis | 23 |
Hopper | 22 |
Cancer | 22 |
WHO | 22 |
Review | 22 |
lopinavir | 22 |
Ethics | 21 |
A | 21 |
Chloroquine | 21 |
Council | 21 |
EU | 21 |
DARIS | 21 |
Human | 21 |
Italy | 21 |
Science | 21 |
Victoria | 21 |
multicentre | 21 |
LIVE@Home | 20 |
DMC | 20 |
Europe | 20 |
Institute | 20 |
May | 20 |
NIH | 20 |
Network | 20 |
nan | 20 |
Medicine | 19 |
Jacobson | 19 |
Azithromycin | 19 |
Assessment | 19 |
IRB | 18 |
Effect | 18 |
Good | 18 |
Madagascar | 18 |
Pandemic | 18 |
M. | 18 |
Monitoring | 18 |
Manis | 18 |
Registry | 17 |
Practice | 17 |
M | 17 |
ICTRP | 17 |
EMA | 17 |
Dementia | 17 |
Conservation | 17 |
Board | 17 |
Act | 17 |
Directive | 16 |
CC | 16 |
CONSORT | 16 |
Conference | 16 |
F | 16 |
East | 16 |
HIV | 16 |
NHS | 16 |
RR | 16 |
Sunda | 15 |
Norwegian | 15 |
Journal | 15 |
January | 15 |
General | 15 |
France | 15 |
Africa | 15 |
Chinese | 14 |
February | 14 |
Development | 14 |
July | 14 |
Centre | 14 |
Association | 14 |
AE | 14 |
III | 14 |
Management | 14 |
Middle | 14 |
Nature | 14 |
Peter | 14 |
Report | 14 |
S3 | 14 |
SD | 14 |
Spain | 14 |
ITT | 13 |
A. | 13 |
Asia | 13 |
CoV | 13 |
December | 13 |
Figure | 13 |
IPM | 13 |
Evaluation | 13 |
PNIF | 13 |
Patients | 13 |
RSV | 13 |
Respiratory | 13 |
Risk | 13 |
Syndrome | 13 |
USA | 13 |
New | 13 |
Control | 12 |
ID | 12 |
Dr. | 12 |
D21 | 12 |
D11 | 12 |
Creative | 12 |
Commons | 12 |
Australia | 12 |
Appendix | 12 |
ALI | 12 |
AC | 12 |
JWBY | 12 |
IQR | 12 |
Patient | 12 |
MAR | 12 |
Springer | 12 |
prednisone | 12 |
NPR | 12 |
kg | 12 |
Working | 12 |
Technology | 12 |
methotrexate | 12 |
Sciences | 12 |
PICU | 12 |
Oxford | 12 |
North | 12 |
Lancet | 11 |
4-year | 11 |
BMJ | 11 |
Bergen | 11 |
CRF | 11 |
Department | 11 |
GenV. | 11 |
Generation | 11 |
Guidance | 11 |
IV | 11 |
Information | 11 |
COVID19 | 11 |
Lopinavir | 11 |
Steering | 11 |
MCAR | 11 |
committee | 11 |
_ | 11 |
Zika | 11 |
www.nature.com/scientificreports/ | 11 |
Statistical | 11 |
S1 | 11 |
RDT | 11 |
QRI | 11 |
Public | 11 |
August | 10 |
Clin | 10 |
England | 10 |
KCDC | 10 |
Foundation | 10 |
Harmonisation | 10 |
Helsinki | 10 |
Innovation | 10 |
Institutional | 10 |
Intent | 10 |
J. | 10 |
TNF | 10 |
Med | 10 |
Supplementary | 10 |
Michael | 10 |
ciprofloxacin | 10 |
Time | 10 |
Systematic | 10 |
TRK | 10 |
South | 10 |
Products | 10 |
Platform | 10 |
Plan | 10 |
HPA | 9 |
Kingdom | 9 |
Institutes | 9 |
Impact | 9 |
IL-23 | 9 |
I(2 | 9 |
Alzheimer | 9 |
H. | 9 |
EC | 9 |
Director | 9 |
DSMB | 9 |
B | 9 |
Al | 9 |
Note | 9 |
PRISMA | 9 |
Prevention | 9 |
Septoplasty | 9 |
© | 9 |
Pro | 9 |
interferon | 9 |
favipiravir | 9 |
apremilast | 9 |
Sun | 9 |
medRxiv | 9 |
Schmitz | 9 |
S6 | 9 |
Randomized | 9 |
RA | 9 |
Project | 9 |
SAP | 9 |
Lung | 8 |
IL-6 | 8 |
Inc. | 8 |
Infection | 8 |
Interventions | 8 |
Ministry | 8 |
MEDLINE | 8 |
Master | 8 |
Model | 8 |
Nasal | 8 |
I | 8 |
IL-17 | 8 |
Novel | 8 |
Huashan | 8 |
GTM | 8 |
Fisher | 8 |
Federal | 8 |
Experimenter | 8 |
D. | 8 |
Chi | 8 |
Center | 8 |
CRP | 8 |
Belmont | 8 |
BE | 8 |
8) | 8 |
Netherlands | 8 |
ECG | 8 |
Oncology | 8 |
S5 | 8 |
Open | 8 |
dexamethasone | 8 |
Y. | 8 |
Wei | 8 |
Southeast | 8 |
Scientific | 8 |
Scale | 8 |
α | 8 |
Saudi | 8 |
Salk | 8 |
SPIRIT | 8 |
SNOT-22 | 8 |
mofetil | 8 |
S4 | 8 |
RUD | 8 |
Ritonavir | 8 |
Protocol | 8 |
PubMed | 8 |
R | 8 |
Pan | 8 |
Recommendations | 8 |
Regulatory | 8 |
Reporting | 8 |
Reviews | 8 |
Regulation | 8 |
Guideline | 7 |
David | 7 |
Declaration | 7 |
Effectiveness | 7 |
Glaser | 7 |
Healthcare | 7 |
Harriett | 7 |
IMP | 7 |
Influenza | 7 |
College | 7 |
Iran | 7 |
Critical | 7 |
COVID‐19 | 7 |
Collaboration | 7 |
Chronic | 7 |
Children | 7 |
Chen | 7 |
CSM | 7 |
CD20 | 7 |
B11 | 7 |
Advisory | 7 |
Adults | 7 |
Acute | 7 |
Access | 7 |
K | 7 |
John | 7 |
Intervention | 7 |
Kluwer | 7 |
Solidarity | 7 |
MFDS | 7 |
β1b | 7 |
https://doi.org/10 | 7 |
Wolters | 7 |
West | 7 |
Vaccine | 7 |
Urquhart | 7 |
Union | 7 |
Theory | 7 |
Test | 7 |
TMG | 7 |
Subjects | 7 |
Unit | 7 |
School | 7 |
PPI | 7 |
Mashhad | 7 |
SAEs | 7 |
N95 | 7 |
ORCHID | 7 |
P. | 7 |
Outcomes | 7 |
Principles | 7 |
Prophylaxis | 7 |
Questionnaire | 7 |
S2 | 7 |
GDPR | 6 |
Initiative | 6 |
Hib | 6 |
Hospitalised | 6 |
Huang | 6 |
ICT | 6 |
IPTp | 6 |
L | 6 |
Jens | 6 |
Jensen | 6 |
Joshua | 6 |
K. | 6 |
London | 6 |
MD | 6 |
Expert | 6 |
Form | 6 |
Apremilast | 6 |
Embase | 6 |
Beaudry | 6 |
NOSE | 6 |
-Preliminary | 6 |
America | 6 |
Arabia | 6 |
BY | 6 |
Bagayogo | 6 |
Bradford | 6 |
Elizabeth | 6 |
Bushen | 6 |
Central | 6 |
Clark | 6 |
Commission | 6 |
Danish | 6 |
Design | 6 |
MIRACLE | 6 |
S7 | 6 |
Novartis | 6 |
Supplemental | 6 |
U.S. | 6 |
Ulrik | 6 |
Utilization | 6 |
W | 6 |
Workshop | 6 |
Yiqi | 6 |
Zelazo | 6 |
alpha-2b | 6 |
biosimilar | 6 |
etanercept | 6 |
mycophenolate | 6 |
pemphigus | 6 |
tocilizumab | 6 |
ORR | 6 |
| | 6 |
TOC | 6 |
homophily | 6 |
Studies | 6 |
Quality | 6 |
PageRank | 6 |
Statement | 6 |
PFS | 6 |
Pangolins | 6 |
Proactive | 6 |
Province | 6 |
Pharmaceutical | 6 |
RRR | 6 |
State | 6 |
Russ | 6 |
S | 6 |
Sarah | 6 |
Registration | 6 |
Government | 5 |
Hub | 5 |
Home | 5 |
Harmonization | 5 |
Garry | 5 |
Global | 5 |
GMO | 5 |
Forum | 5 |
Executive | 5 |
IL-12 | 5 |
Ferneley | 5 |
ICMJE | 5 |
Kong | 5 |
IgM | 5 |
India | 5 |
Investigators | 5 |
Italian | 5 |
Johnson | 5 |
Kristiansand | 5 |
Life | 5 |
MMSE | 5 |
Medline | 5 |
Missing | 5 |
NC | 5 |
Empowerment | 5 |
NCTU | 5 |
Estimands | 5 |
CSB | 5 |
ELISA | 5 |
CT | 5 |
OS | 5 |
< | 5 |
ADL | 5 |
AT | 5 |
Ahuja | 5 |
American | 5 |
B99 | 5 |
Baerum | 5 |
Boards | 5 |
C. | 5 |
CFR | 5 |
CTR | 5 |
Dermatology | 5 |
CVD | 5 |
California | 5 |
Case | 5 |
Ciborra | 5 |
Code | 5 |
Cohen | 5 |
Cohorts | 5 |
Criteria | 5 |
D | 5 |
Davis | 5 |
Denmark | 5 |
NSCLC | 5 |
Thatcher | 5 |
Office | 5 |
bivalirudin | 5 |
Thailand | 5 |
Trade | 5 |
Trust | 5 |
User | 5 |
Video | 5 |
Vietnam | 5 |
Wales | 5 |
Whiten | 5 |
Wu | 5 |
Zamani | 5 |
ant | 5 |
chloroquine | 5 |
Surg | 5 |
doc_id | 5 |
http:// | 5 |
iPhone | 5 |
malaria | 5 |
of-1 | 5 |
s13063 | 5 |
stay | 5 |
steering | 5 |
β-1a | 5 |
κB | 5 |
P | 5 |
TRIN | 5 |
rhesus | 5 |
Stress | 5 |
Regional | 5 |
PCR | 5 |
Sterimar | 5 |
PE | 5 |
PI | 5 |
Pinsonneault | 5 |
Policy | 5 |
Proceedings | 5 |
Proportion | 5 |
Pulmonary | 5 |
RSS | 5 |
Randomised | 5 |
Pharmaceuticals | 5 |
Resource | 5 |
Services | 5 |
S8 | 5 |
Standards | 5 |
Social | 5 |
Shen | 5 |
Sobreperez | 5 |
Scopus | 5 |
Sanofi | 5 |
SDD | 5 |
SAE | 5 |
Spray | 5 |
HemOnc.org | 4 |
HeLTI | 4 |
GP | 4 |
Handbook | 4 |
Gupta | 4 |
Guide | 4 |
Groups | 4 |
4 | |
Gautret | 4 |
F. | 4 |
Frye | 4 |
Forecast | 4 |
Fidock | 4 |
FDAAA | 4 |
EudraCT | 4 |
Editorial | 4 |
Early | 4 |
EV | 4 |
I. | 4 |
E9 | 4 |
Hubei | 4 |
L. | 4 |
INR | 4 |
LMST | 4 |
Dr | 4 |
N | 4 |
Melissa | 4 |
Matthew | 4 |
Marie | 4 |
Mann | 4 |
MNAR | 4 |
Li | 4 |
Jia | 4 |
ITI | 4 |
Japan | 4 |
Items | 4 |
Inventory | 4 |
Integrative | 4 |
Int | 4 |
Informed | 4 |
Imputation | 4 |
IgG | 4 |
E | 4 |
Background | 4 |
Diseases | 4 |
Amgen | 4 |
Bautista | 4 |
Barki | 4 |
B23 | 4 |
Azathioprine | 4 |
Authority | 4 |
Attribution | 4 |
AstraZeneca | 4 |
Andrew | 4 |
Americas | 4 |
Boehringer | 4 |
Alliance | 4 |
Ageing | 4 |
Adaptive | 4 |
Action | 4 |
AR | 4 |
ACC | 4 |
4,3,2,1 | 4 |
NIHR | 4 |
Blood | 4 |
Box | 4 |
Difference | 4 |
Christian | 4 |
DeSanctis | 4 |
Dale | 4 |
Cox | 4 |
Comparative | 4 |
Common | 4 |
Combination | 4 |
Co | 4 |
Ciprofloxacin | 4 |
Chicago | 4 |
Breakthrough | 4 |
ChiCTR | 4 |
Characteristics | 4 |
Centers | 4 |
Carroll | 4 |
CVD103-HgR | 4 |
CTCAE | 4 |
CPL | 4 |
Brosnan | 4 |
NCT | 4 |
Dis | 4 |
Nielsen | 4 |
Systems | 4 |
Wood | 4 |
Women | 4 |
Whitney | 4 |
Western | 4 |
Washington | 4 |
Version | 4 |
Venkatesh | 4 |
VN | 4 |
VEK | 4 |
URTI | 4 |
Truog | 4 |
Treatments | 4 |
Therapy | 4 |
Therapies | 4 |
Thalidomide | 4 |
Team | 4 |
Tang | 4 |
TSC | 4 |
T | 4 |
X | 4 |
Yang | 4 |
Zealand | 4 |
max | 4 |
November | 4 |
yellow | 4 |
ward | 4 |
qPCR | 4 |
pyrimethamine | 4 |
org/ | 4 |
nonresearch | 4 |
monitoring | 4 |
latency | 4 |
Zelen | 4 |
keytruda | 4 |
k0 | 4 |
https | 4 |
gentamicin | 4 |
disease | 4 |
dihydroartemisinin | 4 |
darunavir | 4 |
Zheng | 4 |
± | 4 |
oseltamivir | 4 |
System | 4 |
Pope | 4 |
Qualitative | 4 |
Qin | 4 |
Qi | 4 |
Q | 4 |
Publisher | 4 |
Program | 4 |
Preferred | 4 |
Pradeesh | 4 |
Poole | 4 |
RSI | 4 |
Poisson | 4 |
Pluto | 4 |
Pharmacologic | 4 |
Personal | 4 |
Pediatric | 4 |
PICF | 4 |
Survival | 4 |
Oslo | 4 |
R. | 4 |
PWD | 4 |
Recruitment | 4 |
Sabin | 4 |
Surgery | 4 |
RedCap | 4 |
Shao | 4 |
Shanghai | 4 |
September | 4 |
Seoul | 4 |
Scutellaria | 4 |
San | 4 |
Singh | 4 |
SIV | 4 |
Reports | 4 |
Regeneron | 4 |
Register | 4 |
SF-36 | 4 |
Sivapalan | 4 |
Republic | 4 |
SARs | 4 |
Rubin | 4 |
George | 3 |
G | 3 |
G. | 3 |
GEE | 3 |
GLM | 3 |
GLMM | 3 |
Gentofte | 3 |
Germany | 3 |
Grounded | 3 |
Gibson | 3 |
Gilead | 3 |
Guinea | 3 |
Gopnik | 3 |
Gordon | 3 |
Grants | 3 |
GraphPad | 3 |
Front | 3 |
GlaxoSmithKline | 3 |
Facemasks | 3 |
French | 3 |
Exosurf | 3 |
Elderly | 3 |
Head | 3 |
Elie | 3 |
Emergency | 3 |
English | 3 |
Epidemic | 3 |
Estimators | 3 |
Extension | 3 |
Freeman | 3 |
FAST | 3 |
FULL | 3 |
Favipiravir | 3 |
Feldman | 3 |
Fernandez | 3 |
Figshare | 3 |
File | 3 |
HR | 3 |
JAMA | 3 |
Healthy | 3 |
LIB | 3 |
Jakobsen | 3 |
James | 3 |
Jan | 3 |
Jun | 3 |
KRAS | 3 |
Karnofsky | 3 |
Kenward | 3 |
LLC | 3 |
Holly | 3 |
Laura | 3 |
Lauren | 3 |
Laurence | 3 |
Leukemia | 3 |
Liu | 3 |
Loeb | 3 |
Editors | 3 |
Jakarta | 3 |
JF | 3 |
Isabelle | 3 |
Investigator | 3 |
Hopkins | 3 |
Hussein | 3 |
IL-4 | 3 |
ILI | 3 |
IQCODE | 3 |
ISRCTN | 3 |
ISTp | 3 |
Implementation | 3 |
Inclusivity | 3 |
Independence | 3 |
Independent | 3 |
Infectious | 3 |
Informant | 3 |
Ingelheim | 3 |
Ingraham | 3 |
El | 3 |
Block | 3 |
Economics | 3 |
Baseline | 3 |
Approach | 3 |
Audit | 3 |
Australasian | 3 |
Australian | 3 |
B55 | 3 |
BMC | 3 |
Barrett | 3 |
Bayer | 3 |
Burden | 3 |
Better | 3 |
Betty | 3 |
Bias | 3 |
Biomedical | 3 |
Bivalirudin | 3 |
M3 | 3 |
Blueprint | 3 |
Applied | 3 |
Ann | 3 |
Analyses | 3 |
Ali | 3 |
AA | 3 |
ACP | 3 |
ACTT | 3 |
AHRP | 3 |
ALK | 3 |
AS | 3 |
ASCO | 3 |
AZD1775 | 3 |
Abdullah | 3 |
Abstract | 3 |
Actelion | 3 |
Affairs | 3 |
Ahmad | 3 |
Air | 3 |
Akt | 3 |
Bubo | 3 |
CHMP | 3 |
ENT | 3 |
Daegu | 3 |
Consent | 3 |
Consolidated | 3 |
Controlled | 3 |
Copenhagen | 3 |
Crit | 3 |
Cross | 3 |
Cyclosporine | 3 |
Daily | 3 |
CIOMS | 3 |
Daniel | 3 |
Depression | 3 |
Dexamethasone | 3 |
Distress | 3 |
E6 | 3 |
EEN | 3 |
EMR | 3 |
Committees | 3 |
Cohort | 3 |
Coalition | 3 |
CoV2 | 3 |
COMPARATOR | 3 |
COSMOS | 3 |
COVid-19 | 3 |
CQ | 3 |
CTA | 3 |
Canada | 3 |
Canadian | 3 |
Cardiovascular | 3 |
Census | 3 |
Challenge | 3 |
Chaturvedi | 3 |
Chief | 3 |
Chiesi | 3 |
Child | 3 |
CoV-1 | 3 |
Lucas | 3 |
B67 | 3 |
MCRI | 3 |
Vignette | 3 |
Tropical | 3 |
U | 3 |
UCLA | 3 |
Understanding | 3 |
Vaccines | 3 |
Van | 3 |
Victorian | 3 |
WMA | 3 |
Transl | 3 |
WMD | 3 |
Wang | 3 |
Watzek | 3 |
Wilcoxon | 3 |
Windows | 3 |
York | 3 |
Yu | 3 |
Transmission | 3 |
Trajectories | 3 |
Service | 3 |
Straws | 3 |
Smith | 3 |
Sophie | 3 |
Spanish | 3 |
Speed | 3 |
Standard | 3 |
Start | 3 |
StataCorp | 3 |
Streptomycin | 3 |
Timing | 3 |
Surface | 3 |
Survey | 3 |
Sørensen | 3 |
TWiCS | 3 |
Technical | 3 |
Therapeutic | 3 |
Thoracic | 3 |
Zhao | 3 |
Zihui | 3 |
aids | 3 |
t4-t5 | 3 |
pemphigoid | 3 |
range | 3 |
red | 3 |
sciences | 3 |
series | 3 |
spray | 3 |
square | 3 |
tReated | 3 |
alpha | 3 |
thERapY | 3 |
umifenovir | 3 |
vaccinees | 3 |
van | 3 |
− | 3 |
| 3 |
MI | 3 |
pangolin | 3 |
novaferon | 3 |
marboxil | 3 |
larotrectinib | 3 |
caf-1 | 3 |
control | 3 |
coronavirus-2 | 3 |
crizotinib | 3 |
doi | 3 |
drug | 3 |
dupilumab | 3 |
ePhenome | 3 |
gov | 3 |
green | 3 |
https:// | 3 |
https://doi.org/10.1101/2020.05.30.20117523 | 3 |
iMac | 3 |
indacaterol | 3 |
intErferon | 3 |
Simón | 3 |
areata | 3 |
Sequential | 3 |
Nguyen | 3 |
Multicenter | 3 |
NCT04043364 | 3 |
NF | 3 |
NP | 3 |
Neck | 3 |
Neonatal | 3 |
Newcastle | 3 |
Non | 3 |
PP | 3 |
Nordic | 3 |
ORIGINS | 3 |
OTH | 3 |
OUTCOMES | 3 |
October | 3 |
Oncol | 3 |
Orphan | 3 |
Morrison | 3 |
Mometasone | 3 |
Molenberghs | 3 |
Molecular | 3 |
MIDI | 3 |
Scotland | 3 |
MMF | 3 |
MTX | 3 |
MW | 3 |
MacBook | 3 |
Marshall | 3 |
McGuigan | 3 |
MedImmune | 3 |
Medicinal | 3 |
Mental | 3 |
Method | 3 |
Mini | 3 |
Minimum | 3 |
Mohamed | 3 |
PO | 3 |
Moreno | 3 |
PROSPERO | 3 |
Roche | 3 |
Ratitch | 3 |
Red | 3 |
Regulations | 3 |
Relative | 3 |
Requirements | 3 |
Riyadh | 3 |
Robert | 3 |
Royal | 3 |
RANDOMISED | 3 |
Rubio | 3 |
S. | 3 |
SARS‐CoV‐2 | 3 |
SAS | 3 |
PROTOCOL | 3 |
SOLIDARITY | 3 |
Sci | 3 |
REDCap | 3 |
Rerup | 3 |
Pharma | 3 |
Practices | 3 |
Parent | 3 |
R3 | 3 |
Park | 3 |
Pearson | 3 |
Perspective | 3 |
Placebo | 3 |
Planning | 3 |
Plotnik | 3 |
President | 3 |
Process | 3 |
Product | 3 |
Protections | 3 |
Qing | 3 |
Quercetin | 3 |
PRP | 3 |
HREC | 2 |
HHK | 2 |
HMC | 2 |
HRA | 2 |
Graphs | 2 |
HTA | 2 |
Haemophilus | 2 |
H5N1 | 2 |
Hajj | 2 |
HCSC | 2 |
Griffiths | 2 |
Gorilla | 2 |
H1N1 | 2 |
Gyeongsangbuk | 2 |
Gurmeet | 2 |
Guidelines | 2 |
Guangdong | 2 |
Grasselli | 2 |
Hamazaki | 2 |
Halimi | 2 |
Hospitalized | 2 |
Haraldsplass | 2 |
Hochberg | 2 |
Hu | 2 |
Glostrup | 2 |
Hrubesch | 2 |
Hospitals | 2 |
Horner | 2 |
Horby | 2 |
Hoffman | 2 |
Hodgkin | 2 |
High | 2 |
Hart | 2 |
Her-2 | 2 |
Hennink | 2 |
Heart | 2 |
Headquarters | 2 |
Hb | 2 |
Haun | 2 |
Hassan | 2 |
Harvard | 2 |
Goldfeld | 2 |
Eur | 2 |
Gleevec | 2 |
Evidence | 2 |
FEV1 | 2 |
FDR | 2 |
FAIR | 2 |
F1 | 2 |
Exp | 2 |
Excel | 2 |
Examination | 2 |
Evolution | 2 |
Event | 2 |
Facilitation | 2 |
Eva | 2 |
EusaPharma | 2 |
Ethical | 2 |
Etheredge | 2 |
Española | 2 |
Erik | 2 |
Epidemiol | 2 |
Hypoglycaemia | 2 |
FS | 2 |
Failure | 2 |
Glasgow | 2 |
Francesca | 2 |
Gabriel | 2 |
GOLD | 2 |
GM | 2 |
GF | 2 |
Functional | 2 |
Fudan | 2 |
Franklin | 2 |
Francisco | 2 |
Force | 2 |
Farber | 2 |
Flow | 2 |
Fiona | 2 |
Finland | 2 |
Fernandes | 2 |
Feigenson | 2 |
Fei | 2 |
Federica | 2 |
Fatigue | 2 |
Hygiene | 2 |
Label | 2 |
ICF | 2 |
Kaiser | 2 |
King | 2 |
Kindle | 2 |
Kim | 2 |
Kilwinning | 2 |
Kentucky | 2 |
Kendall | 2 |
Keith | 2 |
Kanchanaburi | 2 |
KJR | 2 |
Koopman | 2 |
KEYNOTE-001 | 2 |
KC | 2 |
K+ | 2 |
Julie | 2 |
Julia | 2 |
Josefin | 2 |
Jordan | 2 |
Jingcheng | 2 |
Knowledge | 2 |
Korean | 2 |
Jean | 2 |
Lambeth | 2 |
Library | 2 |
Liberia | 2 |
Letter | 2 |
Leone | 2 |
Legare | 2 |
Le | 2 |
Laurie | 2 |
Lars | 2 |
Enterprise | 2 |
L1 | 2 |
Lab | 2 |
LSG | 2 |
LOESS | 2 |
LMWH | 2 |
LM | 2 |
LIVING | 2 |
LIBERTY | 2 |
LDH | 2 |
Jeremy | 2 |
Jazz | 2 |
ICUs | 2 |
IRCT20200405046958N1 | 2 |
Individual | 2 |
Indians | 2 |
Improvisation | 2 |
Immunosuppression | 2 |
Immunoglobulin | 2 |
IU | 2 |
ITTI | 2 |
ITCC | 2 |
IRCT | 2 |
Industry | 2 |
IPTW | 2 |
IPD | 2 |
IND | 2 |
IMI | 2 |
IMASOY | 2 |
IL-1 | 2 |
IL | 2 |
IEC | 2 |
Indonesia | 2 |
Inference | 2 |
Janus | 2 |
Introduction- | 2 |
Jaeger | 2 |
JCJ | 2 |
JB | 2 |
J.D.D. | 2 |
Issues | 2 |
Isfahan | 2 |
Investigational | 2 |
Investigation | 2 |
Interventional | 2 |
Informal | 2 |
Internal | 2 |
Intern | 2 |
Interferon | 2 |
Intensive | 2 |
Integrity | 2 |
Integrated | 2 |
Instruments | 2 |
Insects | 2 |
Environment | 2 |
Carolina | 2 |
Ensemble | 2 |
Assumptions | 2 |
B92 | 2 |
B19 | 2 |
B17 | 2 |
B119 | 2 |
B109 | 2 |
B. | 2 |
Avdagic | 2 |
AustralaSian | 2 |
Article | 2 |
BC | 2 |
Arthur | 2 |
Art | 2 |
Arnaud | 2 |
Arjun | 2 |
Arbidol | 2 |
Appropriation | 2 |
Apple | 2 |
Anticoagulation | 2 |
BBB | 2 |
BMI | 2 |
Animal | 2 |
Ben | 2 |
Bruno | 2 |
Bourdin | 2 |
Born | 2 |
Bonferroni | 2 |
Blinded | 2 |
Biobank | 2 |
Bhattacherjee | 2 |
Benelux | 2 |
Behaviour | 2 |
BSH | 2 |
Behavioral | 2 |
Beecher | 2 |
Bauer | 2 |
Based | 2 |
Baojun | 2 |
Baldotto_Clarissa | 2 |
Baillargeon | 2 |
BTs | 2 |
Anne | 2 |
Andrea | 2 |
Enhancement | 2 |
AG | 2 |
ASCOT | 2 |
APTT | 2 |
APC | 2 |
APA | 2 |
ANTI | 2 |
ALVEOLI | 2 |
AIFA | 2 |
AIDS | 2 |
ACTIV | 2 |
AUD | 2 |
ACIS | 2 |
5d | 2 |
500mg | 2 |
3- | 2 |
1C | 2 |
-July | 2 |
-August | 2 |
Lifecourse | 2 |
AUC | 2 |
Aboriginal | 2 |
Ana | 2 |
Agitation | 2 |
Amin | 2 |
Ameer | 2 |
Alison | 2 |
Alireza | 2 |
Alba | 2 |
Airway | 2 |
Ahmed | 2 |
Agreement | 2 |
Advisors | 2 |
Abraham | 2 |
Adjuvant | 2 |
Adjustment | 2 |
Adjusted | 2 |
Adjunctive | 2 |
Adalimumab | 2 |
Accessibility | 2 |
Acceptance | 2 |
Abrar | 2 |
Bu | 2 |
Bubonic | 2 |
C1-C9 | 2 |
Dakota | 2 |
Deputy | 2 |
Dennis | 2 |
Democratic | 2 |
Delphi | 2 |
Decline | 2 |
Deborah | 2 |
Deaconess | 2 |
Davidson | 2 |
DRC | 2 |
Diagnosis | 2 |
DPIA | 2 |
DOASS | 2 |
DJC | 2 |
DIS | 2 |
DC | 2 |
D'Arcy | 2 |
Cyclosporin | 2 |
Curcumin | 2 |
Devices | 2 |
Dignity | 2 |
CKJ | 2 |
EUA | 2 |
Emily | 2 |
Elements | 2 |
Electronic | 2 |
Eklöf | 2 |
Effects | 2 |
Eddy | 2 |
Economy | 2 |
EVD | 2 |
ETF | 2 |
Dong | 2 |
ESMO | 2 |
ERP | 2 |
EQ-5D | 2 |
ECRIN | 2 |
EB | 2 |
E. | 2 |
Duffett | 2 |
Du | 2 |
Creactive | 2 |
Cosaque | 2 |
Cornell | 2 |
Carpenter | 2 |
Checklist | 2 |
Charmaz | 2 |
Charlotte | 2 |
Chanez | 2 |
Chancellor | 2 |
Centered | 2 |
Celgene | 2 |
Cañete | 2 |
Carol | 2 |
Copyright | 2 |
Carey | 2 |
CVD03-HgR | 2 |
CRM | 2 |
CPMs | 2 |
COVID- | 2 |
COV2 | 2 |
CML | 2 |
CLSI | 2 |
Chemotherapy | 2 |
Choudrie | 2 |
Chowdhery | 2 |
Chughtai | 2 |
Context | 2 |
Contamination | 2 |
Consortium | 2 |
Consensus | 2 |
Consensi | 2 |
Congo | 2 |
Computing | 2 |
Comprehensive | 2 |
Comparison | 2 |
Company | 2 |
Commercial | 2 |
Comité | 2 |
Collaborative | 2 |
Cognitive | 2 |
Cmax | 2 |
ClinicalTrials | 2 |
Classification | 2 |
License | 2 |
BYOD | 2 |
Limited | 2 |
TX | 2 |
Tian | 2 |
Thu | 2 |
Thomas | 2 |
Third | 2 |
Th17 | 2 |
Task | 2 |
Tams | 2 |
Tables | 2 |
TSH | 2 |
Times | 2 |
TPP | 2 |
TNW | 2 |
TNFalpha | 2 |
TIDieR | 2 |
Swiss | 2 |
Sweden | 2 |
Swann | 2 |
Swan | 2 |
Tignanelli | 2 |
Together | 2 |
Summary | 2 |
VA | 2 |
Volunteer | 2 |
Volkoff | 2 |
Viscum | 2 |
Vienna | 2 |
Vice | 2 |
Veterinary | 2 |
Veterans | 2 |
Value | 2 |
Utrecht | 2 |
Tor | 2 |
Utilisation | 2 |
UFT | 2 |
Tyne | 2 |
2 | |
TwiCs | 2 |
Tuskegee | 2 |
Triple | 2 |
Torres | 2 |
Sustainability | 2 |
Suehs | 2 |
Wake | 2 |
Safes | 2 |
Sensitivity | 2 |
Sedrakyan | 2 |
Scholar | 2 |
Scheiner | 2 |
Schapiro | 2 |
Scandinavia | 2 |
Sara | 2 |
Saffery | 2 |
SUSAR | 2 |
Shirahada | 2 |
STEMI | 2 |
STATA | 2 |
SSG | 2 |
SPSS | 2 |
SP | 2 |
SMART | 2 |
SLE | 2 |
SJ | 2 |
Sepsis | 2 |
Short | 2 |
Sud | 2 |
Stata | 2 |
Stæhr | 2 |
Streamlined | 2 |
Strait | 2 |
Stomach | 2 |
Stevens | 2 |
Stefan | 2 |
Statistics | 2 |
Station | 2 |
Stahl | 2 |
Shuming | 2 |
Sponsor | 2 |
Solutions | 2 |
Software | 2 |
Singapore | 2 |
Sinai | 2 |
Sierra | 2 |
Sidney | 2 |
Siddiqui | 2 |
W. | 2 |
Walsham | 2 |
SEFAS | 2 |
ki | 2 |
n= | 2 |
ms | 2 |
methylprednisolone | 2 |
maximus | 2 |
mSv | 2 |
mHealth | 2 |
los | 2 |
lme4 | 2 |
key | 2 |
nasendoscopy | 2 |
ixekizumab | 2 |
ivermectin | 2 |
iCAT_SR | 2 |
https://doi.org/10.1038/s41598-020-65898-x | 2 |
homecare | 2 |
europa | 2 |
eu/ | 2 |
ethics | 2 |
n=51 | 2 |
nonexperimental | 2 |
el | 2 |
social | 2 |
Lingwen | 2 |
× | 2 |
À.63 | 2 |
À | 2 |
www.nature.com/scientificreports | 2 |
subgroup | 2 |
streptomycin | 2 |
st | 2 |
sildenafil | 2 |
nonmaleficence | 2 |
sequalae | 2 |
septorhinoplasty | 2 |
scan | 2 |
sarilumab | 2 |
requirement(s | 2 |
preprint | 2 |
piperaquine | 2 |
2 | |
en | 2 |
ec | 2 |
2 | |
Yijie | 2 |
anakinra | 2 |
alopecia | 2 |
ZMapp | 2 |
ZEBOV | 2 |
Z | 2 |
Yubao | 2 |
Ying | 2 |
Yin | 2 |
Xue | 2 |
ance | 2 |
Xa | 2 |
Wyatt | 2 |
Wright | 2 |
Workers | 2 |
WordPress | 2 |
Word | 2 |
Wildlife | 2 |
Wenqian | 2 |
analysis | 2 |
antiXa | 2 |
disease-2019 | 2 |
cobicistat | 2 |
dinutuximab | 2 |
des | 2 |
del | 2 |
data | 2 |
creativecommons | 2 |
covid19 | 2 |
covid-19 | 2 |
colchicine | 2 |
clin | 2 |
appendix | 2 |
clarithromycin | 2 |
calfactant | 2 |
bullous | 2 |
bubo | 2 |
beta-1b | 2 |
beta-1a | 2 |
baloxavir | 2 |
author(s | 2 |
SIOPEN | 2 |
Yersinia | 2 |
SC | 2 |
Muller | 2 |
Nasrallah | 2 |
Naseptin | 2 |
NYT | 2 |
NR3 | 2 |
NAT | 2 |
N. | 2 |
Méditerranée | 2 |
Mycophenolate | 2 |
Mount | 2 |
Nebraska | 2 |
Monitor | 2 |
Mohammad | 2 |
Models | 2 |
Modeling | 2 |
Mobilization | 2 |
Mobile | 2 |
Mo | 2 |
Misinformation | 2 |
Natalie | 2 |
Networking | 2 |
MiPL | 2 |
Oliver | 2 |
Otolaryngol | 2 |
Oseltamivir | 2 |
Orlikowski | 2 |
Organisation | 2 |
Organ | 2 |
Operations | 2 |
Operational | 2 |
Omalizumab | 2 |
Ohio | 2 |
Neuropsychiatric | 2 |
Official | 2 |
Observational | 2 |
Observation | 2 |
Nursing | 2 |
Notch-1 | 2 |
None | 2 |
Nicolas | 2 |
Nicholas | 2 |
Mike | 2 |
Meyer | 2 |
Outbreaks | 2 |
Lynch | 2 |
MHV | 2 |
MHRA | 2 |
MDP | 2 |
MDA | 2 |
MCID | 2 |
MCF-7 | 2 |
MB-231 | 2 |
Lyytinen | 2 |
Lv | 2 |
MR | 2 |
Luminex | 2 |
Luce | 2 |
Longitudinal | 2 |
Long | 2 |
Lombardy | 2 |
SAMMPRIS | 2 |
Livestock | 2 |
Living | 2 |
MOBID | 2 |
MRI | 2 |
Methods | 2 |
Market | 2 |
Merck | 2 |
Medication | 2 |
Mean | 2 |
McGann | 2 |
McCulloch | 2 |
Material | 2 |
Massachusetts | 2 |
Martin | 2 |
Mark | 2 |
MV | 2 |
Marignane | 2 |
Marco | 2 |
Mansfield | 2 |
Mallinckrodt | 2 |
Malawi | 2 |
Malaria | 2 |
Mahidol | 2 |
Mac | 2 |
Outbreak | 2 |
Methodology | 2 |
Ovid | 2 |
Prism | 2 |
Region | 2 |
Reducing | 2 |
Recovery | 2 |
Rebecca | 2 |
Ray | 2 |
Rating | 2 |
RECOVERY | 2 |
RD | 2 |
RANDOMISATION | 2 |
Quintet | 2 |
Qualtrics | 2 |
Qatar | 2 |
QTc | 2 |
QT | 2 |
QALY | 2 |
Q1-Q3 | 2 |
Psychiatry | 2 |
Programme | 2 |
Processes | 2 |
Replication | 2 |
Res | 2 |
ResMan | 2 |
Roundup | 2 |
SAMIT | 2 |
S13 | 2 |
S12 | 2 |
PCAST | 2 |
S11 | 2 |
S-1 | 2 |
Rule | 2 |
Rozina | 2 |
Rossi | 2 |
Reserve | 2 |
Ross | 2 |
Ronald | 2 |
Road | 2 |
RoB | 2 |
Ring | 2 |
Riemer | 2 |
Richard | 2 |
Resveratrol | 2 |
Problem | 2 |
Rep | 2 |
Presence | 2 |
PaO2 | 2 |
Performance | 2 |
Pattern | 2 |
Pascal | 2 |
Parliament | 2 |
Pankaj | 2 |
Pandemics | 2 |
Pallud | 2 |
Paediatric | 2 |
PROTOACCEPT | 2 |
Personnes | 2 |
PPE | 2 |
PIONEER | 2 |
PHP | 2 |
Preparedness | 2 |
PEs | 2 |
PCORI | 2 |
PDE4 | 2 |
PD | 2 |
Permanente | 2 |
Pangolin | 2 |
Population | 2 |
Points | 2 |
Prednisone | 2 |
Precision | 2 |
Pharmacol | 2 |
Practical | 2 |
Potential | 2 |
Portal | 2 |
Porphyria | 2 |
Premkumar | 2 |
Pongo | 2 |
Pregnancy | 2 |
Pneumonia | 2 |
Pierre | 2 |
PhenX | 2 |
Pheromone | 2 |
Philippe | 2 |
Plans | 2 |
Plasma | 2 |
Heaton | 1 |
Healthstar | 1 |
Heather | 1 |
Hazzard | 1 |
Hazards | 1 |
Hazard | 1 |
Hayden | 1 |
Harald | 1 |
Hayley | 1 |
Harbi | 1 |
Harmonised | 1 |
Haug | 1 |
Hatch | 1 |
HasanAbadi | 1 |
Harwood | 1 |
Harthy | 1 |
Harrison | 1 |
Harmonation | 1 |
Hargreaves | 1 |
Hekkala | 1 |
Harborough | 1 |
Hein | 1 |
Hillestad | 1 |
Helen | 1 |
Highlands | 1 |
Hirsch | 1 |
Hanson | 1 |
Historical | 1 |
Hitchings | 1 |
Hindex | 1 |
Himba | 1 |
Himalayas | 1 |
Hillerød | 1 |
Hillary | 1 |
Hill | 1 |
Hierarchy | 1 |
Hell | 1 |
Hidle | 1 |
Heumann | 1 |
Heterogeneous | 1 |
Heterogeneity | 1 |
Hermina | 1 |
Herlev | 1 |
Heparin | 1 |
Hepach | 1 |
Henry | 1 |
Helskinki | 1 |
Hans‐Georg | 1 |
Guilherme | 1 |
Hansen | 1 |
Gyeonggi | 1 |
HER2 | 1 |
HEALTHCARE | 1 |
HCl | 1 |
H1N1pdm09 | 1 |
H1N109 | 1 |
H1N1(09 | 1 |
H | 1 |
Gönül | 1 |
Gökçen | 1 |
Gynecologic | 1 |
Guillaume | 1 |
Hanko | 1 |
Guillain | 1 |
Guido | 1 |
Guiding | 1 |
Guerra | 1 |
Guardian | 1 |
Guard | 1 |
Grupo | 1 |
Hladun | 1 |
Grolleau | 1 |
Griffith | 1 |
HFpEF | 1 |
HIF-1α | 1 |
HIN1 | 1 |
HIN1(09 | 1 |
Hani | 1 |
Hanel | 1 |
Hanan | 1 |
Hamza | 1 |
Hamilton | 1 |
Hameed | 1 |
Hamad | 1 |
Halloran | 1 |
Hale | 1 |
Hague | 1 |
Haenszel | 1 |
Haemostasis | 1 |
Haematology | 1 |
Haddy | 1 |
Hackman | 1 |
Hacid | 1 |
HW | 1 |
HTA)-funded | 1 |
HMO | 1 |
HMGH | 1 |
HITECH | 1 |
Hjorthøj | 1 |
Illustrators | 1 |
Hodgson | 1 |
IL‐12 | 1 |
IU/20 | 1 |
IS | 1 |
IRB)-Independent | 1 |
IR.MUMS.REC.1399.078 | 1 |
IQR114 | 1 |
IOIS | 1 |
IMPACT | 1 |
IML | 1 |
IL‐4/13 | 1 |
IL‐17 | 1 |
IL-8 | 1 |
IECs | 1 |
IL-22 | 1 |
IL-2 | 1 |
IL-1b | 1 |
IL-17-dependent | 1 |
IL-17-deficient | 1 |
IL-13 | 1 |
IL-12p40 | 1 |
IL-12/23p40 | 1 |
IL-12/23 | 1 |
IIa | 1 |
IUCN | 1 |
IVIG | 1 |
IX | 1 |
Ian | 1 |
Gregory | 1 |
Indicators | 1 |
Index | 1 |
Indemnity | 1 |
Inc | 1 |
Inaba | 1 |
InSPiRe | 1 |
Improved | 1 |
Impression | 1 |
Imperial | 1 |
Immunomodulatory | 1 |
Immunol | 1 |
Immortal | 1 |
Imatinib | 1 |
Imani | 1 |
Illness | 1 |
Ill | 1 |
Ignacio | 1 |
IgE | 1 |
Iden | 1 |
Idelalisib | 1 |
IFN)-c | 1 |
IDeAl | 1 |
Hohenberger | 1 |
Hovav | 1 |
Huguet_Francoise | 1 |
Huguet | 1 |
Hughes | 1 |
Hudry | 1 |
Huberman | 1 |
Huarui | 1 |
Hróbjartsson | 1 |
Howraman | 1 |
Howel | 1 |
Howard | 1 |
Houshang | 1 |
ICS | 1 |
Hossein | 1 |
Hospitalier | 1 |
Hormozd | 1 |
Hookway | 1 |
Honiara | 1 |
Hong | 1 |
Holtz | 1 |
Holstein | 1 |
Holland | 1 |
Hohlfeld | 1 |
Hui | 1 |
Humbert | 1 |
Hunter | 1 |
Huo | 1 |
ICMRA | 1 |
ICIS | 1 |
ICD-11 | 1 |
IBM | 1 |
I.M.C. | 1 |
Håkansson | 1 |
Hyponatraemia | 1 |
Hypokalaemia | 1 |
Hypersensitivity | 1 |
Hyperprogressive | 1 |
Hypernatremia | 1 |
Hyperkalaemia | 1 |
Hyperglycaemia | 1 |
Hyperchloremia | 1 |
Hynes | 1 |
Hyeikyoung | 1 |
HydroxyChloroquine | 1 |
Hvidovre | 1 |
Hutchins | 1 |
Husebo | 1 |
Hurricane | 1 |
Greve | 1 |
EudraLex | 1 |
Greer | 1 |
Faraj | 1 |
Fed | 1 |
Febuxostat | 1 |
Feb | 1 |
Fatehi | 1 |
Faso | 1 |
Farrar | 1 |
Farran | 1 |
Farouk | 1 |
Farmaco | 1 |
Fargen | 1 |
Fanlong | 1 |
Fit | 1 |
Familiarisation | 1 |
Faiza | 1 |
Faisal | 1 |
Fahey | 1 |
Fahad | 1 |
Fagot | 1 |
Fadnes | 1 |
Faculty | 1 |
Facetime | 1 |
1 | |
Federation | 1 |
Fehizoro | 1 |
Feinberg | 1 |
Felix | 1 |
First | 1 |
Fiorella | 1 |
Findability | 1 |
Final | 1 |
Filip | 1 |
Figs | 1 |
Fiction | 1 |
FiO2 | 1 |
FiO | 1 |
Fezeu | 1 |
Fever | 1 |
Ferrand | 1 |
Feron | 1 |
Fernández | 1 |
Fernyhough | 1 |
Fergus | 1 |
Feras | 1 |
Feno | 1 |
Feng | 1 |
Fellowship | 1 |
Feller | 1 |
Fabri | 1 |
FVC | 1 |
FTEs | 1 |
Essai | 1 |
Escherichia | 1 |
Error | 1 |
Ernest | 1 |
Erin | 1 |
Erich | 1 |
Eric | 1 |
Eran | 1 |
Equity | 1 |
Equipment | 1 |
EqualContrib | 1 |
Epimedy | 1 |
Eosinophilia | 1 |
Enzmann | 1 |
Enya | 1 |
Environmental | 1 |
Enhancing | 1 |
Englert | 1 |
Endpoints | 1 |
End | 1 |
Empiricist | 1 |
Empirical | 1 |
Eslami | 1 |
Establishment | 1 |
FR | 1 |
Estimating | 1 |
FOCA | 1 |
FO | 1 |
FGH | 1 |
FEV | 1 |
FC | 1 |
FB | 1 |
FAS | 1 |
FA | 1 |
Extract | 1 |
Exploratory | 1 |
Explor | 1 |
Exacerbation | 1 |
Evrenoglou | 1 |
Everardo | 1 |
Evaluability | 1 |
Eusa | 1 |
Eureka | 1 |
Eugene | 1 |
Infected | 1 |
Etemad | 1 |
Estimation | 1 |
Fishers | 1 |
Five | 1 |
Green | 1 |
Gerontopsychiatric | 1 |
Gilles | 1 |
Gillen | 1 |
Giaglis | 1 |
Giacomo | 1 |
Ghosn | 1 |
Ghazawi | 1 |
Ghazal | 1 |
Ghanizada | 1 |
Ghaleb | 1 |
Ghaem | 1 |
Geriatric | 1 |
Fleischner | 1 |
Geographical | 1 |
Geneva | 1 |
Genentech | 1 |
Gene | 1 |
Gender | 1 |
GenVcollected | 1 |
Gellsinger | 1 |
Gedde | 1 |
Gash | 1 |
Garrison | 1 |
Gillesen | 1 |
Gini | 1 |
Gitte | 1 |
Giulia | 1 |
Graña | 1 |
Granulomatosis | 1 |
Granule | 1 |
Grandma | 1 |
Grand | 1 |
Graff | 1 |
Graduates | 1 |
Grading | 1 |
Grabitz | 1 |
Gowers | 1 |
Governance | 1 |
Gottlieb | 1 |
Goods | 1 |
Goodman | 1 |
Gong | 1 |
Gold | 1 |
Gobet | 1 |
Go | 1 |
Gluud | 1 |
Glossary | 1 |
Giuseppe | 1 |
García | 1 |
Gandini | 1 |
Gamez | 1 |
Frederick | 1 |
Fraser | 1 |
François | 1 |
Francoise | 1 |
Frances | 1 |
Fragmented | 1 |
Fowler | 1 |
Fouweather | 1 |
Foundations | 1 |
Fouet | 1 |
Forward | 1 |
Fortina | 1 |
Forms | 1 |
Formosan | 1 |
Formal | 1 |
Forecasts | 1 |
Focus | 1 |
Flynn | 1 |
FluCAN | 1 |
Florida | 1 |
Fletcher | 1 |
Fleming | 1 |
Fraud | 1 |
Frederickson | 1 |
Gamana | 1 |
Fremont | 1 |
Galapagos | 1 |
Gaborit | 1 |
GT | 1 |
GRECCO-19 | 1 |
GPs | 1 |
GOLG | 1 |
GMP | 1 |
GMOs | 1 |
GDS | 1 |
GC | 1 |
Fæø | 1 |
Fyfe | 1 |
Fuzheng | 1 |
Future | 1 |
Furman | 1 |
Functioning | 1 |
Fulminant | 1 |
Frøydis | 1 |
Frode | 1 |
Fris | 1 |
Friede | 1 |
Inf | 1 |
Korica | 1 |
Inferno | 1 |
Ltd. | 1 |
MACRO | 1 |
M.Y. | 1 |
Lyons | 1 |
Lynn | 1 |
Lymphoid | 1 |
Lydia | 1 |
Luxembourg | 1 |
Lundgren | 1 |
Luchetti | 1 |
Luca | 1 |
Ltd | 1 |
Little | 1 |
Low | 1 |
Louisiana | 1 |
Loubna | 1 |
Lorusso | 1 |
Longini | 1 |
Logit | 1 |
Loehr | 1 |
Local | 1 |
Lloyd | 1 |
Liver | 1 |
MAMS | 1 |
MAP | 1 |
MBSR | 1 |
MDS | 1 |
MacIntyre | 1 |
Maarja | 1 |
MRC-05 | 1 |
MRC | 1 |
MP | 1 |
MMRM | 1 |
ML | 1 |
MIR | 1 |
MIP-1a | 1 |
MIND | 1 |
MINC | 1 |
MHV-3 | 1 |
MHG | 1 |
MH | 1 |
MF | 1 |
METOP | 1 |
MET | 1 |
MESIFOS | 1 |
MEH | 1 |
MEC | 1 |
MDs | 1 |
LiveJournal | 1 |
Literature | 1 |
Lance | 1 |
Lausanne | 1 |
Lehana | 1 |
Legrand | 1 |
Lee | 1 |
Led | 1 |
Leah | 1 |
Leadership | 1 |
Leaders | 1 |
Lazio | 1 |
Laws | 1 |
Lawrence | 1 |
Laursen | 1 |
Lisbeth | 1 |
Laufer | 1 |
Lasciate | 1 |
Larson | 1 |
Larotrectinib | 1 |
Largent | 1 |
Large | 1 |
Lapperre | 1 |
Lapointe | 1 |
Laplace | 1 |
Langerak | 1 |
Lei | 1 |
Leila | 1 |
Lenz | 1 |
Leon | 1 |
Lipocurc | 1 |
Linux | 1 |
Linnaeus | 1 |
Line | 1 |
Linderoth | 1 |
Lindegaard | 1 |
Lincoln | 1 |
Lincocin | 1 |
Lina | 1 |
Lim | 1 |
Light | 1 |
Libron | 1 |
Libray | 1 |
Liang | 1 |
Levina | 1 |
Leukin | 1 |
Lessons | 1 |
Leslie | 1 |
Lesaffre | 1 |
Leopold | 1 |
Leonardi | 1 |
Macbook | 1 |
Macomber | 1 |
Maculopathy | 1 |
Mayouya | 1 |
Meade | 1 |
MeSH | 1 |
MeNTS | 1 |
McNicholas | 1 |
McLin | 1 |
McLeod | 1 |
McHugh | 1 |
McFadden | 1 |
Mazzarella | 1 |
Mazwi | 1 |
Maymunah | 1 |
Madewell | 1 |
Mavuto | 1 |
Mavridis | 1 |
Maurizio | 1 |
Mauricia | 1 |
Matthieu | 1 |
Matthias | 1 |
Matthews | 1 |
Matt | 1 |
Mathilde | 1 |
Mathanga | 1 |
Measles | 1 |
Measurement | 1 |
Measures | 1 |
Meat | 1 |
Meredith | 1 |
Merchant | 1 |
Memish | 1 |
Members | 1 |
Member | 1 |
Melvin | 1 |
Mellitus | 1 |
Melbourne | 1 |
Melanoma | 1 |
Mekhlafi | 1 |
Meier | 1 |
Meguerditchian | 1 |
Megan | 1 |
Meeting | 1 |
Meerpohl | 1 |
Mediterranean | 1 |
Medidas | 1 |
Medicamentos | 1 |
MedRxiv | 1 |
Mechanism | 1 |
Mechanical | 1 |
Maternal | 1 |
Materials | 1 |
Matching | 1 |
Manufacturers | 1 |
Mannseth | 1 |
Manidae | 1 |
Mangahasimbola | 1 |
Mandourah | 1 |
Manager | 1 |
Mamy | 1 |
Mammalia | 1 |
Mammal | 1 |
Malty | 1 |
Malik | 1 |
Malar | 1 |
Mala | 1 |
Majid | 1 |
Majed | 1 |
MainStage | 1 |
Mahillo | 1 |
Magpix | 1 |
Magni | 1 |
Maechler | 1 |
Mady | 1 |
Madsen | 1 |
Mantel | 1 |
Manufacturing | 1 |
Mass | 1 |
Mao | 1 |
Mask | 1 |
Marusich | 1 |
Martínez | 1 |
Martinsons | 1 |
Marseille | 1 |
Marraro | 1 |
Marnoch | 1 |
Marinus | 1 |
Marinette | 1 |
Maria | 1 |
Margie | 1 |
Marcus | 1 |
Marcovitch | 1 |
Marciano | 1 |
Marchenko | 1 |
March-12th | 1 |
Marcel | 1 |
Marc | 1 |
Marboxil | 1 |
Map1-LC3b | 1 |
Map | 1 |
Landscape | 1 |
Lalitpur | 1 |
Inflexibility | 1 |
Jabbar | 1 |
JavaScript | 1 |
Jasperson | 1 |
Jasper | 1 |
Japanese | 1 |
Janner | 1 |
Janne | 1 |
Janet | 1 |
Jane | 1 |
Jaffuel | 1 |
Jacobsen | 1 |
JWBY)-Bushen | 1 |
Islands | 1 |
JRCT | 1 |
JPD | 1 |
JP | 1 |
JL | 1 |
JAW | 1 |
J.L.W.Reprints | 1 |
J.L. | 1 |
Ivy | 1 |
Ivan | 1 |
Italiana | 1 |
Jeffrey | 1 |
Jehovah | 1 |
Jeon | 1 |
Jeraisy | 1 |
Jonsson | 1 |
Jones | 1 |
Jonathan | 1 |
Jon | 1 |
Jokhdar | 1 |
Joint | 1 |
Johnston | 1 |
Johns | 1 |
Joerg | 1 |
Jodacare | 1 |
Joal | 1 |
Jin | 1 |
Jie | 1 |
Jicha | 1 |
Jiangsu | 1 |
Jessika | 1 |
Jessica | 1 |
Jesse | 1 |
Jess | 1 |
Jesna | 1 |
Jerome | 1 |
Israel | 1 |
Islander | 1 |
Laird | 1 |
Innovative | 1 |
Interdependence | 1 |
Interactive | 1 |
Inter | 1 |
Intensity | 1 |
Integr | 1 |
Institut | 1 |
Instillation | 1 |
Inspiratory | 1 |
Insitute | 1 |
Insect | 1 |
Innovations | 1 |
Island | 1 |
Injury | 1 |
Injuries | 1 |
Injection | 1 |
Inhibitors | 1 |
Inhibition | 1 |
Ingi | 1 |
Ingeheim | 1 |
Infrastructure | 1 |
Informativeness | 1 |
Infliximab | 1 |
Interdisciplinary | 1 |
Intergrating | 1 |
Interim | 1 |
Interleukin-1 | 1 |
Irish | 1 |
Ira | 1 |
Ipsit | 1 |
Ipilimumab | 1 |
Ipads | 1 |
Iowa | 1 |
Ionescu | 1 |
Inès | 1 |
Involvement | 1 |
Investigations | 1 |
Inverse | 1 |
Intravenous | 1 |
Intra | 1 |
Interval | 1 |
Interv | 1 |
Interrupted | 1 |
Interrater | 1 |
Interpretability | 1 |
Interoperability | 1 |
Intermittent | 1 |
Interleukin-6 | 1 |
Joondalup | 1 |
Joost | 1 |
Jose | 1 |
Kjell | 1 |
Krag | 1 |
Kotsimbos | 1 |
Emmanuel | 1 |
Komarek | 1 |
Kojan | 1 |
Knottnerus | 1 |
Knop | 1 |
Klingenberg | 1 |
Kjome | 1 |
Kjerstad | 1 |
Kirsten | 1 |
Joseph | 1 |
Kirkham | 1 |
Kirkevold | 1 |
Kirchhof | 1 |
Kirby | 1 |
Kiran | 1 |
Kineret | 1 |
Kieser | 1 |
Kidney | 1 |
Ki67 | 1 |
Khatami | 1 |
Kristian | 1 |
Kristin | 1 |
Kristine | 1 |
Krokeide | 1 |
Laffey | 1 |
Laboratorybased | 1 |
Laboratory | 1 |
La | 1 |
LT | 1 |
LRTI | 1 |
LR | 1 |
LMH | 1 |
LIVE@Home.-Path | 1 |